Modeling microglia activation and inflammation-based neuroprotectant strategies during ischemic stroke

From MaRDI portal
Publication:2035779

DOI10.1007/S11538-021-00905-4zbMATH Open1467.92052arXiv2010.07473OpenAlexW3161146935WikidataQ113900158 ScholiaQ113900158MaRDI QIDQ2035779FDOQ2035779


Authors: Sara Amato, Andrea Arnold Edit this on Wikidata


Publication date: 25 June 2021

Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)

Abstract: Neural inflammation immediately follows the onset of ischemic stroke. During this process, microglial cells can be activated into two different phenotypes: the M1 phenotype, which can worsen brain injury by producing pro-inflammatory cytokines; or the M2 phenotype, which can aid in long term recovery by producing anti-inflammatory cytokines. In this study, we formulate a nonlinear system of differential equations to model the activation of microglia post-ischemic stroke, which includes bidirectional switching between the microglia phenotypes, as well as the interactions between these cells and the cytokines that they produce. Further, we explore neuroprotectant-based modeling strategies to suppress the activation of the detrimental M1 phenotype, while promoting activation of the beneficial M2 phenotype. Through use of global sensitivity techniques, we analyze the effects of the model parameters on the ratio of M1 to M2 microglia and the total number of activated microglial cells in the system over time. Results demonstrate the significance of bidirectional microglia phenotype switching on the ratio of M1 to M2 microglia, in both the absence and presence of neuroprotectant terms. Simulations further suggest that early inhibition of M1 activation and support of M2 activation leads to a decreased minimum ratio of M1 to M2 microglia and allows for a larger number of M2 than M1 cells for a longer time period.


Full work available at URL: https://arxiv.org/abs/2010.07473




Recommendations




Cites Work


Cited In (3)





This page was built for publication: Modeling microglia activation and inflammation-based neuroprotectant strategies during ischemic stroke

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2035779)